Brazil and Colombia sign agreement for reliance initiatives and information exchange
Updates
Published in
Oct 29, 2020 11:58 AM
Updated in
Mar 08, 2026 10:13 PM
Panels were dedicated to sharing experience and proposing regulatory innovations.
Following good security practices is vital when changing your password.
Joint action with the Ministry of Health National Immunization Program will develop additional studies
Due to the Ebola outbreak in Congo, preventive monitoring protocols were implemented in Brazil
The new product Ozivy underwent a rigorous technical evaluation of efficacy, safety and quality.
WHO’s initiative takes place in Switzerland and Brazilian delegation participates in debates on equity, access to health, pandemics, artificial intelligence and antimicrobial resistance
Regulatory authorities from both countries reaffirmed their commitment to strengthen technical cooperation.
Results will help investigations to assess health risks posed by irregular injectable GLP-1 medications
Meeting brought together members of the U.S. Chamber of Commerce and the Brazil-U.S. Business Council
Project reinforces regulatory capacities in the pharmaceutical, food and health sectors
Anvisa receives Mexican delegation and highlights the importance of partnerships to face post-pandemic challenges
Representatives from Brazil, Chile, Colombia, Cuba, Mexico, Paraguay, and Panama signed the document.
Brazil and Paraguay sign agreement to improve health surveillance standards in Latin America
Letter of suitability gains a new layout and is now issued in a faster and automated way
Agreement strengthens relations and promotes collaboration in health and science
Listed products are parameters of therapeutic efficacy, safety and quality
Agenda aims to strengthen bilateral cooperation focusing on technology transfer to Brazil
Among the topics discussed at the event is regulatory harmonization in health
Measure has been unanimously approved.
New visual identity reflects care, closeness, and a commitment to public health.
In addition to the repealed norms, the validity of Resolution RDC 456/2020 expired.
Since Microsoft decided to discontinue the Internet Explorer, Anvisa recommends the use of the Internet Explorer Mode in Microsoft Edge.
New tool facilitates access to the Agency's information.
Regulatory changes will improve controlled substances monitoring and inspection procedures.
Vaccination and tests are no longer necessary.
Rules optimize the approval of drug products, biological products, and vaccines.
The event took place on November 5 and 6 at Anvisa headquarters in Brasília.
Anvisa publishes an updated version with guidelines .
Anvisa has updated technical notes with recommendations on ports, vessels, airports and aircraft.